Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nadia Carenina Nunes Cavalcante Parr"'
Autor:
Atlantis Dawn Russ, Ahmad Iftikhar, Kevin Gee, Sabina Saeed, Mirza Saqib Baig, Steffan T. Nawrocki, Ali McBride, Jason Valent, Nadia Carenina Nunes Cavalcante Parr, Jennifer S. Carew, Christy J. Samaras, Faryal Razzaq, Hussam Al-Kateb, Muhammad Abu Zar, Faiz Anwer
Publikováno v:
Clin Lymphoma Myeloma Leuk
Multiple myeloma (MM) is genetically complex disease. Identification of mutations and aberrant signaling pathways that contribute to the progression of MM and drug resistance has potential to lead to specific targets and personalized treatment. Aberr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3923fca21c63aa492ba283441ebea774
https://doi.org/10.1016/j.clml.2019.03.017
https://doi.org/10.1016/j.clml.2019.03.017
Autor:
Zeeshan Baig, Seren Durer, Muhammad Junaid Tariq, Muhammad Usman, Ali Younas Khan, Muhammad Asad Fraz, Nadia Carenina Nunes Cavalcante Parr, Saad Ullah Malik, Atlantis Dawn Russ, Ceren Durer, Faiz Anwer, Warda Faridi, Fnu Sagar, Awais Ijaz, Ali McBride, Zeeshan Ali
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:94-99
Investigators are using checkpoint inhibitors (CPIs) to treat aggressive hematologic malignancies in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and in some patients with relapsed disease after allo-HSCT. CTLA-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c26247d7e5e7c8c54edf58fa00bab36f
https://doi.org/10.1016/j.bbmt.2018.08.028
https://doi.org/10.1016/j.bbmt.2018.08.028
Autor:
Charisse Te, Jaclyn Leong, Maryam T Fazel, Merri Pendergrass, Nadia Carenina Nunes Cavalcante Parr
Publikováno v:
Journal of the Endocrine Society
Introduction: Insulin resistance occurs most commonly in association with obesity but may result from multiple causes, e.g. medications, lipodystrophy, or antibodies to insulin or insulin receptors. We review a case of an unusual presentation of insu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e31be804833d6e3930ce80b361eb3913
http://europepmc.org/articles/PMC7207577
http://europepmc.org/articles/PMC7207577
Publikováno v:
Journal of the Endocrine Society
Background: Subacute thyroiditis (SAT) is a transient inflammatory disorder of the thyroid gland, whereas Hashimoto thyroiditis (HT) is an autoimmune disorder. These two disease entities have quite different pathogenic mechanisms and typically do not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b74970d05dbf657a10c5ee326dad3fee
http://europepmc.org/articles/PMC7208498
http://europepmc.org/articles/PMC7208498
Autor:
Ahmad Iftikhar, Afia Ashraf, Faiz Anwer, Nadia Carenina Nunes Cavalcante Parr, Atlantis Dawn Russ, Ahsan Wahab, Abhijeet Kumar, Prem Kumar Thirunagari, Aida Siyahian, Ammara Majeed
Publikováno v:
Journal of Clinical Oncology. 37:e19043-e19043
e19043 Background: Mantle Cell Lymphoma (MCL) is generally treated with rituximab (R) in combination with other drugs. However, treatment for relapsed or refractory (RR) MCL is challenging. For Ibrutinib (Ibr), we aim to determine the efficacy in com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adba04280edb463499b45e69640d7511
https://doi.org/10.1200/jco.2019.37.15_suppl.e19043
https://doi.org/10.1200/jco.2019.37.15_suppl.e19043
Autor:
Malik Qistas Ahmad, Ceren Durer, Ahmad Safdar, Muhammad Junaid Tariq, Muhammad Yasir, Awais Ijaz, Saher Nasir Amin, Muhammad Usman, Seren Durer, Sharoon Samuel, Nadia Carenina Nunes Cavalcante Parr, Faiz Anwer, Muhammad Jahanzeb Khalil, Muhammad Asad Fraz
Publikováno v:
Blood. 132:5656-5656
Introduction Immunotherapy using monoclonal antibodies (mAbs) have been gaining significance in the treatment of multiple myeloma (MM). These include naked antibodies, checkpoint inhibitors (CPIs), novel bispecific mAbs targeting two epitopes and ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82358cf9a24455dd9ff1684adae9e6e6
https://doi.org/10.1182/blood-2018-99-114224
https://doi.org/10.1182/blood-2018-99-114224
Autor:
Awais Ijaz, Mustafa Nadeem Malik, Ceren Durer, Abdul Rafae, Faiz Anwer, Nadia Carenina Nunes Cavalcante Parr, Muhammad Junaid Tariq, Jemin Aby Jose, Seren Durer, Hafiz Muhammad Fazeel, Ali Younas Khan, Muhammad Jahanzeb Khalil, Muhammad Asad Fraz, Muhammad Usman
Publikováno v:
Blood. 132:5477-5477
Introduction Myelofibrosis (MF), a BCR-ABL negative myeloproliferative neoplasm (MPN), has an annual incidence of 1 in 100000 for the primary MF and 0.3-0.7 in 100000 for secondary MF in the USA. MF patients have a median survival of 6.5 years. The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11b3cb8162b4c705de87b30490e309aa
https://doi.org/10.1182/blood-2018-99-115408
https://doi.org/10.1182/blood-2018-99-115408
Autor:
Maria J. Serafini, Nadia Carenina Nunes Cavalcante Parr, Muhammad Sardar, Faiz Anwer, Shaunak Pandya, Christine Chiu
Publikováno v:
Blood. 132:5763-5763
Background Light-chain (AL) amyloidosis is a multi-organ amyloid deposition disease caused by misfolded protein aggregation. Current treatments have improved overall (OS) and progression-free survival (PFS) but challenges remain in improving therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08fffd0e75f254000a28c2c71ad59d21
https://doi.org/10.1182/blood-2018-99-118964
https://doi.org/10.1182/blood-2018-99-118964